Coskun M - Search Results

1

Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease.

Steenholdt C, Coskun M, Buhl S, Bendtzen K, Ainsworth MA, Brynskov J, Nielsen OH. Steenholdt C, et al. Among authors: coskun m. Medicine (Baltimore). 2016 Apr;95(16):e3417. doi: 10.1097/MD.0000000000003417. Medicine (Baltimore). 2016. PMID: 27100432 Free PMC article. Clinical Trial.

2

Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review.

Nielsen OH, Ainsworth M, Coskun M, Weiss G. Nielsen OH, et al. Among authors: coskun m. Medicine (Baltimore). 2015 Jun;94(23):e963. doi: 10.1097/MD.0000000000000963. Medicine (Baltimore). 2015. PMID: 26061331 Free PMC article. Review.

3

Will novel oral formulations change the management of inflammatory bowel disease?

Nielsen OH, Seidelin JB, Ainsworth M, Coskun M. Nielsen OH, et al. Among authors: coskun m. Expert Opin Investig Drugs. 2016 Jun;25(6):709-18. doi: 10.1517/13543784.2016.1165204. Epub 2016 Mar 28. Expert Opin Investig Drugs. 2016. PMID: 26967267 Review.

4

TNF-α-induced down-regulation of CDX2 suppresses MEP1A expression in colitis.

Coskun M, Olsen AK, Holm TL, Kvist PH, Nielsen OH, Riis LB, Olsen J, Troelsen JT. Coskun M, et al. Biochim Biophys Acta. 2012 Jun;1822(6):843-51. doi: 10.1016/j.bbadis.2012.01.012. Epub 2012 Feb 3. Biochim Biophys Acta. 2012. PMID: 22326557 Free article.

5

The role and advances of immunomodulator therapy for inflammatory bowel disease.

Nielsen OH, Coskun M, Steenholdt C, Rogler G. Nielsen OH, et al. Among authors: coskun m. Expert Rev Gastroenterol Hepatol. 2015 Feb;9(2):177-89. doi: 10.1586/17474124.2014.945914. Epub 2014 Aug 7. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25101818 Review.

6

Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.

Coskun M, Steenholdt C, de Boer NK, Nielsen OH. Coskun M, et al. Clin Pharmacokinet. 2016 Mar;55(3):257-74. doi: 10.1007/s40262-015-0316-9. Clin Pharmacokinet. 2016. PMID: 26255287 Review.

7

Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases.

Olesen CM, Coskun M, Peyrin-Biroulet L, Nielsen OH. Olesen CM, et al. Among authors: coskun m. Pharmacol Ther. 2016 Mar;159:110-9. doi: 10.1016/j.pharmthera.2016.01.001. Epub 2016 Jan 22. Pharmacol Ther. 2016. PMID: 26808166 Review.

8

Novel Targeted Therapies for Inflammatory Bowel Disease.

Coskun M, Vermeire S, Nielsen OH. Coskun M, et al. Trends Pharmacol Sci. 2017 Feb;38(2):127-142. doi: 10.1016/j.tips.2016.10.014. Epub 2016 Dec 1. Trends Pharmacol Sci. 2017. PMID: 27916280 Review.

9

Sphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease.

Nielsen OH, Li Y, Johansson-Lindbom B, Coskun M. Nielsen OH, et al. Among authors: coskun m. Trends Mol Med. 2017 Apr;23(4):362-374. doi: 10.1016/j.molmed.2017.02.002. Epub 2017 Mar 8. Trends Mol Med. 2017. PMID: 28283249 Review.

10

MAP kinases in inflammatory bowel disease.

Coskun M, Olsen J, Seidelin JB, Nielsen OH. Coskun M, et al. Clin Chim Acta. 2011 Mar 18;412(7-8):513-20. doi: 10.1016/j.cca.2010.12.020. Epub 2010 Dec 23. Clin Chim Acta. 2011. PMID: 21185271 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

510 results

Search Page

Filters